Subscribe
vectorchef-shutterstock-com-1
vectorchef / Shutterstock.com
19 January 2016Americas

CAFC: same judges can rule on IPR petition and patent validity

The US Court of Appeals for the Federal Circuit has ruled that the same three administrative patent law judges who determine whether to institute an inter partes review (IPR) can also rule on the validity of the patent at issue.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
IPR process creates bias, Ethicon says
1 March 2016   The Patent Trial and Appeal Board’s process of allowing the same three judges to decide whether to institute an inter partes review and on the validity of the patent in question creates legal biases, Ethicon Endo-Surgery has argued.


Editor's picks

Life sciences leaders recognised at LSPN Awards USA 2025
Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025

Editor's picks

Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025

More on this story

Americas
IPR process creates bias, Ethicon says
1 March 2016   The Patent Trial and Appeal Board’s process of allowing the same three judges to decide whether to institute an inter partes review and on the validity of the patent in question creates legal biases, Ethicon Endo-Surgery has argued.

More on this story

Americas
IPR process creates bias, Ethicon says
1 March 2016   The Patent Trial and Appeal Board’s process of allowing the same three judges to decide whether to institute an inter partes review and on the validity of the patent in question creates legal biases, Ethicon Endo-Surgery has argued.

More features

Life sciences leaders recognised at LSPN Awards USA 2025
UK-India trade deal is ‘a missed opportunity for UK pharma’, says industry body
LSPN: Counsel grapple with AI’s impact on training and critical thinking
'Nothing can stand in the way of our work': Ukraine resumes IP system
LSPN: Trump's policy storm causing chaos and confusion
Taylor Wessing expands in Europe with Paris team
LSPN: Using ‘the patentee’s friend’ in Section 112 claims
ResMed voids sleep apnoea tech patent at PTAB